Early Access — free while we kick the tires
EdgarHawk

Castle Jeremy

Chief Operating Officer

Officer
1 filing analyzed · 1 company · Latest 2025-03-28

Companies

Company Buys Sells Direction
Oncology Institute, Inc. TOI 1 0 Net buying

Activity

March 2025
high
Buy
9,056 shares
$9,434
Significance 7/10

COO Jeremy Castle buys 9,056 shares at $1.04 amid cluster of 7 other insider purchases in 14 days

Jeremy Castle, Chief Operating Officer, purchased 9,056 shares at $1.04 on 2025-03-26, increasing his holdings by 11.1% to 90,386 shares. This transaction is part of a cluster pattern with 7 other insiders purchasing within the same 14-day window. The company is unprofitable with net income of $-16,113,000.00, though revenue reached $99,901,000.00 in the latest quarter and grew 21.3% year-over-year. The stock is currently trading at $1.14, down 38.0% from its 52-week high of $1.84 but up 19.2% over the past 30 days and 260.2% over 90 days. The coordinated buying activity by multiple insiders warrants attention to whether executives perceive recent weakness as a contrarian opportunity or view the operational and financial trajectory as undervalued relative to near-term prospects.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access